Bristol Myers Squibb Co. (BMY)
57.67
-1.66
(-2.80%)
USD |
NYSE |
Apr 07, 16:00
58.41
+0.74
(+1.28%)
Pre-Market: 05:35
Bristol Myers Squibb R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median